🇺🇸 FDA
Pipeline program

Ropivacaine Hydrochloride 10 MG/ML [Naropin]

20201180HX

Unknown small_molecule active

Quick answer

Ropivacaine Hydrochloride 10 MG/ML [Naropin] for Colorectal Cancer is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Colorectal Cancer
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials